Defining a future role for radiogenic therapy

Joseph Michael Kaminski, R. J. Kaminski, A. P. Dicker, J. L.C. Urbain

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The goal of cancer therapy is to eliminate the cancer and/or to arrest further growth while decreasing normal tissue toxicity, i.e. to increase the therapeutic ratio. This review focuses on a group of therapeutics that are either (1) directly stimulated by radiation to produce either directly or indirectly cytotoxic agents (i.e. genes under the control of a radiation inducible promoter that produce a cytotoxic protein or an enzyme that converts a prodrug to an active form, respectively); (2) auger-electron emitting radiolabelled oligonucleotides, antibodies, nucleotide analogues, or other small molecules that are internalized; (3) radiation inducible genes that produce a ligand or transporter (or the like) which then can be targeted by cytotoxic agents (e.g. radiolabelled substance). We have termed this group of therapeutics radiogenic therapy.

Original languageEnglish (US)
Pages (from-to)289-294
Number of pages6
JournalCancer Treatment Reviews
Volume27
Issue number5
DOIs
StatePublished - Jan 1 2001

Fingerprint

Cytotoxins
Radiation
Therapeutics
Prodrugs
Oligonucleotides
Genes
Neoplasms
Nucleotides
Electrons
Ligands
Antibodies
Enzymes
Growth
Proteins

Keywords

  • Antibody
  • Cancer
  • Genes
  • Radiation
  • Somatostatin

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging

Cite this

Kaminski, J. M., Kaminski, R. J., Dicker, A. P., & Urbain, J. L. C. (2001). Defining a future role for radiogenic therapy. Cancer Treatment Reviews, 27(5), 289-294. https://doi.org/10.1053/ctrv.2001.0236

Defining a future role for radiogenic therapy. / Kaminski, Joseph Michael; Kaminski, R. J.; Dicker, A. P.; Urbain, J. L.C.

In: Cancer Treatment Reviews, Vol. 27, No. 5, 01.01.2001, p. 289-294.

Research output: Contribution to journalArticle

Kaminski, JM, Kaminski, RJ, Dicker, AP & Urbain, JLC 2001, 'Defining a future role for radiogenic therapy', Cancer Treatment Reviews, vol. 27, no. 5, pp. 289-294. https://doi.org/10.1053/ctrv.2001.0236
Kaminski JM, Kaminski RJ, Dicker AP, Urbain JLC. Defining a future role for radiogenic therapy. Cancer Treatment Reviews. 2001 Jan 1;27(5):289-294. https://doi.org/10.1053/ctrv.2001.0236
Kaminski, Joseph Michael ; Kaminski, R. J. ; Dicker, A. P. ; Urbain, J. L.C. / Defining a future role for radiogenic therapy. In: Cancer Treatment Reviews. 2001 ; Vol. 27, No. 5. pp. 289-294.
@article{4eb5d88c12134fb18094a1785e88a1be,
title = "Defining a future role for radiogenic therapy",
abstract = "The goal of cancer therapy is to eliminate the cancer and/or to arrest further growth while decreasing normal tissue toxicity, i.e. to increase the therapeutic ratio. This review focuses on a group of therapeutics that are either (1) directly stimulated by radiation to produce either directly or indirectly cytotoxic agents (i.e. genes under the control of a radiation inducible promoter that produce a cytotoxic protein or an enzyme that converts a prodrug to an active form, respectively); (2) auger-electron emitting radiolabelled oligonucleotides, antibodies, nucleotide analogues, or other small molecules that are internalized; (3) radiation inducible genes that produce a ligand or transporter (or the like) which then can be targeted by cytotoxic agents (e.g. radiolabelled substance). We have termed this group of therapeutics radiogenic therapy.",
keywords = "Antibody, Cancer, Genes, Radiation, Somatostatin",
author = "Kaminski, {Joseph Michael} and Kaminski, {R. J.} and Dicker, {A. P.} and Urbain, {J. L.C.}",
year = "2001",
month = "1",
day = "1",
doi = "10.1053/ctrv.2001.0236",
language = "English (US)",
volume = "27",
pages = "289--294",
journal = "Cancer Treatment Reviews",
issn = "0305-7372",
publisher = "W.B. Saunders Ltd",
number = "5",

}

TY - JOUR

T1 - Defining a future role for radiogenic therapy

AU - Kaminski, Joseph Michael

AU - Kaminski, R. J.

AU - Dicker, A. P.

AU - Urbain, J. L.C.

PY - 2001/1/1

Y1 - 2001/1/1

N2 - The goal of cancer therapy is to eliminate the cancer and/or to arrest further growth while decreasing normal tissue toxicity, i.e. to increase the therapeutic ratio. This review focuses on a group of therapeutics that are either (1) directly stimulated by radiation to produce either directly or indirectly cytotoxic agents (i.e. genes under the control of a radiation inducible promoter that produce a cytotoxic protein or an enzyme that converts a prodrug to an active form, respectively); (2) auger-electron emitting radiolabelled oligonucleotides, antibodies, nucleotide analogues, or other small molecules that are internalized; (3) radiation inducible genes that produce a ligand or transporter (or the like) which then can be targeted by cytotoxic agents (e.g. radiolabelled substance). We have termed this group of therapeutics radiogenic therapy.

AB - The goal of cancer therapy is to eliminate the cancer and/or to arrest further growth while decreasing normal tissue toxicity, i.e. to increase the therapeutic ratio. This review focuses on a group of therapeutics that are either (1) directly stimulated by radiation to produce either directly or indirectly cytotoxic agents (i.e. genes under the control of a radiation inducible promoter that produce a cytotoxic protein or an enzyme that converts a prodrug to an active form, respectively); (2) auger-electron emitting radiolabelled oligonucleotides, antibodies, nucleotide analogues, or other small molecules that are internalized; (3) radiation inducible genes that produce a ligand or transporter (or the like) which then can be targeted by cytotoxic agents (e.g. radiolabelled substance). We have termed this group of therapeutics radiogenic therapy.

KW - Antibody

KW - Cancer

KW - Genes

KW - Radiation

KW - Somatostatin

UR - http://www.scopus.com/inward/record.url?scp=0035186694&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035186694&partnerID=8YFLogxK

U2 - 10.1053/ctrv.2001.0236

DO - 10.1053/ctrv.2001.0236

M3 - Article

C2 - 11871865

AN - SCOPUS:0035186694

VL - 27

SP - 289

EP - 294

JO - Cancer Treatment Reviews

JF - Cancer Treatment Reviews

SN - 0305-7372

IS - 5

ER -